Last $0.92 USD
Change Today 0.00 / 0.00%
Volume 104.4K
IMSC On Other Exchanges
Symbol
Exchange
OTC US
As of 8:10 PM 02/27/15 All times are local (Market data is delayed by at least 15 minutes).

implant sciences corp (IMSC) Snapshot

Open
$0.90
Previous Close
$0.92
Day High
$0.93
Day Low
$0.89
52 Week High
09/11/14 - $1.82
52 Week Low
02/18/15 - $0.71
Market Cap
67.5M
Average Volume 10 Days
177.6K
EPS TTM
$-0.34
Shares Outstanding
73.4M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for IMPLANT SCIENCES CORP (IMSC)

Related News

No related news articles were found.

implant sciences corp (IMSC) Related Businessweek News

No Related Businessweek News Found

implant sciences corp (IMSC) Details

Implant Sciences Corporation, together with its subsidiaries, develops, manufactures, and sells sensors and systems for the security, safety, and defense industries primarily in the United States and internationally. Its products include Quantum Sniffer QS-H150 portable explosives detector for the simultaneous detection of explosives particulates and vapors with or without physical contact and in real-time; and Quantum Sniffer QS-B220 desktop explosives and narcotics detector for the detection and identification of various military, commercial, and improvised explosives, as well as narcotics. Implant Sciences offers its products for use in aviation and transportation security, high threat facilities and infrastructure, military installations, customs and border protection, and mail and cargo screening. The company markets and sells its products through direct sales and marketing staff, as well as through a network of independent and specialized sales representatives, and distributors. Implant Sciences Corporation was founded in 1984 and is headquartered in Wilmington, Massachusetts.

74 Employees
Last Reported Date: 09/29/14
Founded in 1984

implant sciences corp (IMSC) Top Compensated Officers

Chief Executive Officer and Director
Total Annual Compensation: $270.0K
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $230.0K
Vice President of Technology
Total Annual Compensation: $200.0K
Vice President of Sales & Marketing
Total Annual Compensation: $245.0K
Compensation as of Fiscal Year 2014.

implant sciences corp (IMSC) Key Developments

Implant Sciences Corp. Announces Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended December 31, 2014

Implant Sciences Corp. announced unaudited consolidated earnings results for the second quarter and six months ended December 31, 2014. For the quarter, revenues were $2,141,000 against $3,150,00 a year ago. The decrease in revenue is due primarily to: a 31.6% decrease in the number of QS-B220 desktop units sold in the three months ended December 31, 2014, due to decreased shipments to U.S. air cargo screening facilities in the current three month period and a 3.6% decrease in the average unit sales prices, which resulted in a 34.0% decrease in QS-B220 revenues; a 25.0% decrease in the number of QS-H150 handheld units sold, compared to the prior period, due to decreased shipments to Japan and a 15.6% decrease in the average unit sales prices, which resulted in a 36.7% decrease in QS-H150 revenues,  offset partially by a 50.4% increase in sales of parts and supplies. Loss from operation was $4,119,000 against $2,707,000 a year ago. Net loss was $6,244,000 against $4,381,000 a year ago. Net loss per share, basic and diluted was $0.09 against $0.07 a year ago. Adjusted LBITDA was $3,515,000 against $1,891,000 a year ago. The increase in the net loss is primarily due to costs incurred due to the resignation of former CEO, decreased sales and gross margin and an increase in interest expense. For the six months, revenues were $4,010,000 against $4,315,00 a year ago. Loss from operation was $7,460,000 against $7,133,000 a year ago. Net loss was $11,619,000 against $10,402,000 a year ago. Net loss per share, basic and diluted was $0.17 against $0.18 a year ago. Adjusted LBITDA was $5,843,000 against $4,598,000 a year ago.

Implant Sciences Corp. to Report Q2, 2015 Results on Feb 17, 2015

Implant Sciences Corp. announced that they will report Q2, 2015 results on Feb 17, 2015

Implant Sciences Corp., Q2 2015 Earnings Call, Feb 17, 2015

Implant Sciences Corp., Q2 2015 Earnings Call, Feb 17, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
IMSC:US $0.92 USD 0.00

IMSC Competitors

Market data is delayed at least 15 minutes.

Company Last Change
CR Bard Inc $169.14 USD -1.80
View Industry Companies
 

Industry Analysis

IMSC

Industry Average

Valuation IMSC Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact IMPLANT SCIENCES CORP, please visit www.implantsciences.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.